C4 Imaging, a medical device development company, announced last week that it has received a $1.32 million Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute of the National Institutes of Health.
The grant is to help fund the company’s development of a multi-modality imaging marker, which will be based on its own Sirius MRI Marker. That development will include pre-clinical and clinical testing, to be performed with help from the University of Texas MD Anderson Cancer Center.
"This phase II SBIR award is a significant achievement for us," Andrew Bright, president and CEO of C4 Imaging, said in a statement. "It provides over $1 Million to support the further development of our patented C4 technology. With this award, we can now accelerate our plans to develop additional MRI focused products for cancer patients within a large and growing MRI market."